biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sniper007on Feb 14, 2013 3:12pm

208 Views

Post# 20990525

RE: RE: RE: RE: Shire

Put 2 and 2 together and what do you have? Buyout! The writing is on the wall but it should come as no surprise. On the one hand, I love it! The other says "RH, hold on as long as you can and prove this thing out". Maybe RH will broker the deal of a lifetime for us though. Awfully quiet indeed. The calm before the explosion perhaps?

Anyone care to speculate as to when BTI is bought out, will it be a share swap or cash deal for shareholders?

Sniper

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario